Viewing Study NCT00561418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-05-23 @ 6:01 AM
Study NCT ID: NCT00561418
Status: COMPLETED
Last Update Posted: 2015-07-16
First Post: 2007-11-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult diffuse large cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult Hodgkin lymphoma View
None recurrent mantle cell lymphoma View
None adult nasal type extranodal NK/T-cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None stage III adult T-cell leukemia/lymphoma View
None stage IV adult T-cell leukemia/lymphoma View
None small intestine lymphoma View
None anaplastic large cell lymphoma View